Hearing Diagnosis Instrument Sales

Hearing Diagnosis Instrument Sales Market Outlook

The global hearing diagnosis instrument market is projected to reach a significant valuation of approximately USD 3.5 billion by 2035, growing at a compound annual growth rate (CAGR) of around 6.8% during the forecast period from 2025 to 2035. This growth is driven by an increasing prevalence of hearing disorders, driven by factors such as aging populations, rising noise pollution levels, and greater awareness of hearing health. Furthermore, technological advancements in audiometric devices, including the integration of artificial intelligence and enhanced digital features, are set to revolutionize how hearing disorders are diagnosed and managed. The aging global population particularly contributes to the surge in demand for effective diagnostic tools, as age-related hearing loss becomes more pronounced. Moreover, expanding healthcare infrastructure in emerging economies is facilitating access to advanced hearing diagnosis technologies, further boosting market growth.

Growth Factor of the Market

One of the primary growth factors for the hearing diagnosis instrument market stems from the rising prevalence of hearing impairments globally. As per estimates provided by the World Health Organization (WHO), over 1.5 billion people worldwide currently experience some form of hearing loss, a number projected to increase significantly due to factors such as urbanization and exposure to high-decibel environments. Additionally, the increased focus on preventive healthcare and early diagnosis is leading healthcare providers to invest more significantly in advanced diagnostic tools, creating a conducive environment for market growth. Government initiatives aimed at improving auditory health, coupled with growing awareness campaigns about the importance of hearing assessments, are further propelling market expansion. The rapid technological advancements in hearing diagnostic instruments, such as the development of portable and user-friendly devices, have also become a crucial factor, making hearing assessments more accessible to a larger population. Finally, the rise of telehealth services, especially after the COVID-19 pandemic, has fostered the development of remote audiological testing capabilities, enhancing the market's growth trajectory.

Key Highlights of the Market

• Projected market size of USD 3.5 billion by 2035.
• CAGR of 6.8% from 2025 to 2035.
• Rising prevalence of hearing disorders globally.
• Government initiatives promoting auditory health awareness.
• Technological advancements leading to more accessible diagnostic tools.

By Product Type

Audiometer:

Audiometers are among the most widely used instruments for hearing diagnosis, particularly due to their ability to assess hearing acuity in different frequency ranges. These devices are essential in identifying the degree and type of hearing loss, enabling healthcare professionals to make informed decisions regarding treatment options. The demand for audiometers has been greatly influenced by increased screenings for early detection of hearing impairments, especially in pediatric and geriatric populations. Furthermore, advancements in audiometer technology, such as the emergence of portable and digital versions, have made it easier for practitioners to conduct hearing tests in various settings, including remote areas. The growing awareness of hearing health among consumers is driving the adoption of audiometers in both clinical and home environments, leading to a steady growth trajectory for this segment.

Tympanometer:

Tympanometry plays a crucial role in the assessment of middle ear function by measuring the mobility of the eardrum in response to varying air pressures. This diagnostic tool is pivotal in identifying conditions such as otitis media, eustachian tube dysfunction, and other middle ear disorders. The increasing incidence of middle ear infections, particularly in children, is a key driver for the tympanometer segment. Moreover, the integration of tympanometry with other audiometric tests enhances diagnostic accuracy, leading to a growing preference for these multi-functional devices among healthcare professionals. As healthcare facilities continue to upgrade their diagnostic capabilities, the demand for advanced tympanometers is expected to rise, contributing positively to market growth.

Otoacoustic Emissions System:

The otoacoustic emissions (OAE) system is vital for evaluating the cochlea's function, specifically the outer hair cells. Its non-invasive nature makes it particularly suitable for newborn hearing screenings and for patients who may have difficulty participating in traditional audiometric testing. The growing emphasis on early diagnosis of hearing impairments, especially in infants and children, has significantly boosted the demand for OAE systems. Furthermore, advancements in OAE technology, including the development of portable devices, have enhanced their usability in diverse settings, including clinics and home healthcare. The ongoing efforts by health authorities to implement universal newborn hearing screening programs globally are expected to further drive the adoption of OAE systems, thereby expanding this market segment.

Auditory Brainstem Response System:

The auditory brainstem response (ABR) system is a sophisticated diagnostic tool used to assess the function of the auditory pathway from the ear to the brainstem. This equipment is crucial for diagnosing hearing impairments in children, particularly those who cannot provide behavioral responses during hearing tests. The increasing utilization of ABR in newborn screening programs is significantly propelling the segment, as early detection of hearing loss can lead to timely interventions, positively impacting language development. As the market shifts towards more advanced and integrated healthcare solutions, the demand for ABR systems is expected to grow steadily. Furthermore, technological advancements, such as the miniaturization of ABR devices and the incorporation of digital features, are enhancing their appeal and accessibility in clinical settings.

Otoscope:

Otoscopes are fundamental tools used for the visual examination of the ear canal and eardrum, assisting in the diagnosis of various ear disorders. The versatility and ease of use associated with otoscopes make them a staple in both primary care and specialized audiology settings. The rising incidence of ear-related ailments, such as infections and wax build-up, is driving the demand for otoscopes as practitioners seek efficient diagnostic methods. Furthermore, advancements in otoscope technology, including the advent of digital otoscopes that provide high-resolution imaging, are enhancing diagnostic capabilities and improving clinical outcomes. The growing focus on enhancing patient experience and ensuring accurate diagnoses further supports the expansion of the otoscope segment within the hearing diagnosis instruments market.

By Application

Hospitals:

Hospitals represent a significant application segment within the hearing diagnosis instrument market, as they are equipped to handle a wide range of audiological assessments and treatments. The increasing prevalence of hearing disorders necessitates comprehensive diagnostic services, making hospitals a primary setting for patients seeking evaluation and treatment. The integration of advanced auditory testing technologies in hospitals enhances the quality of care provided to patients, contributing to their growing reliance on these institutions for hearing healthcare. Additionally, with the increasing emphasis on interdisciplinary collaboration in healthcare, hospitals are increasingly adopting hearing diagnosis instruments to facilitate holistic patient assessments and improve treatment outcomes. The rising funding for healthcare infrastructure globally is further expected to bolster the growth of this segment.

Audiology Clinics:

Audiology clinics are specialized centers that focus on diagnosing and managing hearing disorders, making them a critical application segment for hearing diagnosis instruments. The growing awareness and acceptance of audiology services among the general populace are driving more individuals to seek specialized care in these clinics. Audiologists use a range of diagnostic instruments to perform comprehensive assessments, ensuring accurate diagnoses and personalized treatment plans. Furthermore, advancements in technology and an increase in the availability of portable and home-based diagnostic tools are enabling audiology clinics to extend their services beyond traditional settings, enhancing accessibility for patients. As the demand for audiological care continues to rise, the importance of audiology clinics in the hearing diagnosis instruments market is expected to grow substantially.

ENT Clinics:

Ear, Nose, and Throat (ENT) clinics serve as vital healthcare facilities equipped to diagnose and treat a variety of auditory and otologic disorders. The prevalence of hearing-related ailments, including chronic ear infections and balance disorders, often leads patients to seek services from ENT specialists. These clinics utilize an array of hearing diagnosis instruments to conduct thorough assessments, which are essential for developing effective treatment strategies. Given the increasing incidence of hearing loss among all age groups, the demand for ENT services continues to grow, leading to a higher consumption of hearing diagnosis instruments. Additionally, the focus on integrated healthcare solutions is driving ENT clinics to adopt advanced audiometric technologies, enhancing the quality of patient care.

Research Institutes:

Research institutes play a pivotal role in the advancement of hearing diagnosis technologies through ongoing studies and clinical trials aimed at innovating new solutions. These institutions require advanced hearing diagnosis instruments to conduct comprehensive research and contribute to the growing body of knowledge regarding auditory health. The pursuit of developing more effective diagnostic methods and treatments for hearing disorders often drives the demand for cutting-edge audiometric devices within research settings. Collaboration between research institutions and healthcare providers is also fostering the integration of new technologies into clinical practice, further enhancing the market for hearing diagnosis instruments. As research efforts continue to expand, especially in addressing emerging auditory health challenges, the significance of research institutes in the market will continue to grow.

Others:

This segment encompasses various other applications for hearing diagnosis instruments, including but not limited to school screenings, occupational health assessments, and home healthcare settings. The increasing recognition of the importance of early detection of hearing impairments has led to the implementation of hearing screenings in schools, thereby driving demand for portable audiometric devices. Similarly, occupational health programs are adopting hearing assessments to ensure employee safety in noise-exposed environments. As healthcare becomes more patient-centered, home healthcare solutions incorporating hearing diagnosis instruments are also gaining traction, contributing to the overall expansion of this market segment. The shift toward preventive healthcare practices and the rising awareness of auditory health in non-traditional settings will continue to bolster the growth of the "Others" application segment.

By Distribution Channel

Direct Sales:

Direct sales remain a prominent distribution channel for hearing diagnosis instruments, providing manufacturers with a direct line of communication and engagement with healthcare providers and institutions. This channel enables manufacturers to offer personalized service, including product demonstrations, technical support, and tailored pricing, which can be crucial for the adoption of advanced diagnostic tools. Furthermore, direct sales facilitate a deeper understanding of customer needs and market trends, allowing manufacturers to develop products that meet specific demands. The trend of enhanced training and education provided by manufacturers through direct sales is also proving beneficial in promoting the effective utilization of hearing diagnosis instruments. As healthcare facilities increasingly prefer tailored and comprehensive solutions, the direct sales channel is likely to maintain its strong presence in the market.

Distributor Sales:

Distributor sales represent a significant channel for the distribution of hearing diagnosis instruments, providing access to a wider customer base across varying geographical regions. Distributors often have established relationships with healthcare providers, enabling them to effectively promote and sell a range of audiometric devices. The advantages of utilizing distributor networks include increased market reach, logistical support, and enhanced customer service capabilities. As the demand for hearing diagnosis instruments continues to grow, distributors are positioned to expand their offerings and adapt to market changes, ensuring the availability of the latest technologies to healthcare practitioners. The combination of distributor expertise and the manufacturers' innovative solutions is expected to drive the overall growth of this distribution channel within the market.

By User

Adults:

The adult population represents a significant user segment in the hearing diagnosis instrument market, primarily due to the rising prevalence of age-related hearing loss and occupational exposure to noise. As individuals age, the risk of developing hearing impairments increases, leading to greater demand for effective diagnostic tools to assess their auditory health. Additionally, the growing awareness of the importance of regular hearing assessments among adults is encouraging more individuals to seek services from audiologists and healthcare providers. The increasing availability of user-friendly and portable audiometric devices is also facilitating access to screening for adults, further driving the market. As public health initiatives continue to emphasize the importance of hearing health, the adult user segment is expected to maintain a robust growth trajectory in the coming years.

Pediatrics:

The pediatric population forms an essential user segment within the hearing diagnosis instrument market, driven by the need for early detection of hearing impairments in infants and children. The early identification of hearing loss is crucial for effective intervention and language development, prompting healthcare providers to incorporate routine hearing screenings in newborn and childhood care. The increasing implementation of universal newborn hearing screening programs across various countries has significantly boosted the demand for specialized audiometric devices designed for pediatric use. Additionally, the adoption of non-invasive and child-friendly diagnostic tools is making it easier for healthcare professionals to conduct assessments in a comfortable environment. As awareness about childhood auditory health grows, the pediatric user segment is poised for substantial growth.

By Region

The North American region remains a dominant player in the hearing diagnosis instrument market, largely attributed to advanced healthcare infrastructure, high awareness levels regarding hearing health, and a robust presence of leading manufacturers. The United States and Canada are witnessing significant investments in technological advancements, contributing to the region's growth. With the market projected to grow at a CAGR of approximately 7.5% over the next decade, North America is expected to continue leading the way in technological innovation and adoption of hearing diagnosis instruments. Furthermore, increased funding for audiological research and ongoing public health initiatives aimed at addressing hearing loss issues are likely to reinforce the region's market positioning.

In Europe, the hearing diagnosis instrument market is also experiencing considerable growth, driven by an aging population and increasing prevalence of hearing disorders. The region is anticipated to witness a CAGR of around 6.2% during the forecast period, as healthcare providers increasingly focus on enhancing their diagnostic capabilities. Countries such as Germany, France, and the UK are leading the charge in the adoption of advanced hearing diagnostic technologies. Additionally, the European Union’s initiatives aimed at promoting audiological health and improving accessibility to hearing healthcare services are further boosting market prospects. The combination of favorable demographics and proactive healthcare policies is expected to propel the growth of the hearing diagnosis instrument market in Europe.

Opportunities

The hearing diagnosis instrument market is rife with opportunities owing to the rising global awareness regarding hearing impairments and the importance of early diagnosis. As educational campaigns and public health initiatives emphasize the need for regular hearing assessments, the potential for growth in the market remains robust. The increasing integration of technology in healthcare, particularly advancements such as tele-audiology, is creating new avenues for delivering hearing diagnosis services. This shift towards remote healthcare solutions allows for increased accessibility, particularly in underserved populations, thereby expanding the market reach for companies specializing in hearing diagnostic instruments. Additionally, the growing trend of personalized healthcare is leading to the development of tailored diagnostic solutions, further enhancing market opportunities.

Moreover, the aging population worldwide presents substantial opportunities for the hearing diagnosis instrument market. With age-related hearing loss becoming increasingly prevalent, there is a pressing need for effective diagnostic tools to manage this condition. The continuous innovation and development of advanced hearing diagnosis instruments, such as AI-based devices and mobile applications, are poised to capture the interest of healthcare providers and patients alike. Companies that can adapt to the evolving demands of auditory healthcare and leverage emerging technologies are likely to gain a competitive edge in this expanding market. Furthermore, partnerships and collaborations between healthcare providers and technology developers could pave the way for innovative solutions that address the complexities of hearing disorders, leading to substantial growth opportunities for the market overall.

Threats

Despite the promising growth prospects for the hearing diagnosis instrument market, there are several threats that could potentially hinder its progress. One significant challenge is the high cost associated with advanced diagnostic instruments, which may limit accessibility for smaller healthcare facilities and practices, particularly in developing regions. Additionally, the ongoing fluctuations in regulatory policies and reimbursement frameworks across different countries can create uncertainty for manufacturers and healthcare providers, affecting investment decisions and market stability. Furthermore, the emergence of alternative diagnostic methods, including self-assessment tools and mobile applications, could pose a threat to traditional hearing diagnosis instruments as consumers seek more cost-effective and convenient solutions. The rapid pace of technological advancements necessitates continuous innovation, and companies that fail to keep up with industry trends may face challenges in maintaining competitiveness.

Another notable threat is the increasing competition in the hearing diagnosis instrument market, which is becoming more saturated with new entrants and established players alike. As more companies strive to capture market share, price competition may intensify, potentially undermining profit margins for manufacturers. Additionally, the global supply chain disruptions experienced during recent years have highlighted vulnerabilities in manufacturing and distribution processes, leading to potential delays in product availability and shipment. Companies must also navigate the complexities of sourcing high-quality components for their diagnostic devices, as shortages in raw materials could further impact production levels. As the market landscape evolves, addressing these threats will be crucial for maintaining sustainable growth within the hearing diagnosis instrument market.

Competitor Outlook

• GN Store Nord A/S
• Sonova Holding AG
• Demant A/S
• Amplifon S.p.A.
• WS Audiology
• Starkey Hearing Technologies
• Oticon A/S
• Hearing Life
• Rexton
• Audina Hearing Instruments
• Unitron
• Cochlear Limited
• Medtronic plc
• William Demant Holding A/S
• Hearing Solutions

The competitive landscape of the hearing diagnosis instrument market is characterized by a mix of established players and emerging companies, all striving to innovate and capture market share. Leading companies such as GN Store Nord A/S and Sonova Holding AG are recognized for their advanced technological solutions and extensive product portfolios that cater to a diverse range of auditory healthcare needs. These market leaders are heavily investing in research and development to enhance their product offerings and maintain a competitive edge. Moreover, strategic partnerships, acquisitions, and collaborations are common strategies employed by these companies to enhance their market presence and leverage complementary capabilities. The emphasis on sustainability and eco-friendly practices is also becoming increasingly important in shaping the competitive dynamics of the market.

Additionally, firms like Demant A/S and Amplifon S.p.A. are actively expanding their global reach through strategic alliances and distribution agreements, which not only broadens their customer base but also enhances their service capabilities. These companies are also focusing on personalized services and customized product solutions, aligning their offerings with the needs and preferences of varied user demographics, such as adults and pediatrics. Furthermore, the rise of digital technologies has prompted many players in the industry to adapt their business models, including the integration of online sales channels to improve accessibility and convenience for consumers. This trend is likely to continue shaping the competitive landscape as market participants adapt to the evolving needs of healthcare providers and patients.

Some other notable companies such as Starkey Hearing Technologies and Cochlear Limited are making significant strides in the market by introducing innovative hearing diagnosis instruments that leverage advanced technologies. Starkey, in particular, is known for its cutting-edge hearing aids equipped with AI capabilities that enhance user experience and auditory performance. Cochlear Limited, on the other hand, specializes in implantable hearing solutions, expanding the range of options available for individuals with severe hearing loss. The commitment of these companies to advancing auditory healthcare through technological innovations underscores the competitive nature of the hearing diagnosis instrument market, pushing all players to continuously enhance their offerings and deliver effective solutions to consumers.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Rexton
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Unitron
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Demant A/S
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Oticon A/S
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Hearing Life
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 WS Audiology
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Medtronic plc
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Amplifon S.p.A.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Cochlear Limited
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 GN Store Nord A/S
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Hearing Solutions
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Sonova Holding AG
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Audina Hearing Instruments
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 William Demant Holding A/S
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Starkey Hearing Technologies
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Hearing Diagnosis Instrument Sales Market, By User
    • 6.1.1 Adults
    • 6.1.2 Pediatrics
  • 6.2 Hearing Diagnosis Instrument Sales Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Audiology Clinics
    • 6.2.3 ENT Clinics
    • 6.2.4 Research Institutes
    • 6.2.5 Others
  • 6.3 Hearing Diagnosis Instrument Sales Market, By Product Type
    • 6.3.1 Audiometer
    • 6.3.2 Tympanometer
    • 6.3.3 Otoacoustic Emissions System
    • 6.3.4 Auditory Brainstem Response System
    • 6.3.5 Otoscope
  • 6.4 Hearing Diagnosis Instrument Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Hearing Diagnosis Instrument Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Hearing Diagnosis Instrument Sales market is categorized based on

By Product Type

• Audiometer
• Tympanometer
• Otoacoustic Emissions System
• Auditory Brainstem Response System
• Otoscope

By Application

• Hospitals
• Audiology Clinics
• ENT Clinics
• Research Institutes
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales

By User

• Adults
• Pediatrics

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• GN Store Nord A/S
• Sonova Holding AG
• Demant A/S
• Amplifon S.p.A.
• WS Audiology
• Starkey Hearing Technologies
• Oticon A/S
• Hearing Life
• Rexton
• Audina Hearing Instruments
• Unitron
• Cochlear Limited
• Medtronic plc
• William Demant Holding A/S
• Hearing Solutions